Akari Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKTX and other ETFs, options, and stocks.About AKTX
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor.
CEOAbizer Gaslightwala
CEOAbizer Gaslightwala
Employees9
Employees9
HeadquartersTampa, Florida
HeadquartersTampa, Florida
Founded2004
Founded2004
Employees9
Employees9
AKTX Key Statistics
Market cap10.87M
Market cap10.87M
Price-Earnings ratio-0.05
Price-Earnings ratio-0.05
Dividend yield—
Dividend yield—
Average volume1.86M
Average volume1.86M
High today$0.3589
High today$0.3589
Low today$0.3281
Low today$0.3281
Open price$0.35
Open price$0.35
Volume134.45K
Volume134.45K
52 Week high$1.73
52 Week high$1.73
52 Week low$0.2918
52 Week low$0.2918
Stock Snapshot
As of today, Akari Therapeutics(AKTX) shares are valued at $0.33. The company's market cap stands at 10.87M, with a P/E ratio of -0.05.
As of 2025-12-06, Akari Therapeutics(AKTX) stock has fluctuated between $0.33 and $0.36. The current price stands at $0.33, placing the stock +1.3% above today's low and -7.4% off the high.
Akari Therapeutics(AKTX) shares are trading with a volume of 134.45K, against a daily average of 1.86M.
In the last year, Akari Therapeutics(AKTX) shares hit a 52-week high of $1.73 and a 52-week low of $0.29.
In the last year, Akari Therapeutics(AKTX) shares hit a 52-week high of $1.73 and a 52-week low of $0.29.